Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement

BACKGROUND: Basal insulin and premix insulin are commonly prescribed first-line insulin therapies for patients failing to maintain glycaemic control on oral therapy. When control on these insulins starts to drift, premix analogues, such as biphasic insulin aspart 30/70 (BIAsp 30), are a simple and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Unnikrishnan, A G, Tibaldi, J, Hadley-Brown, M, Krentz, A J, Ligthelm, R, Damci, T, Gumprecht, J, Gerő, L, Mu, Y, Raz, I
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780562/
https://www.ncbi.nlm.nih.gov/pubmed/19780866
http://dx.doi.org/10.1111/j.1742-1241.2009.02192.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780562/
https://www.ncbi.nlm.nih.gov/pubmed/19780866
http://dx.doi.org/10.1111/j.1742-1241.2009.02192.x

Ejemplares similares